A detailed history of Darden Wealth Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Darden Wealth Group Inc holds 4,577 shares of ABBV stock, worth $920,892. This represents 0.47% of its overall portfolio holdings.

Number of Shares
4,577
Previous 4,159 10.05%
Holding current value
$920,892
Previous $757 Million 3.66%
% of portfolio
0.47%
Previous 0.59%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $64,702 - $75,557
418 Added 10.05%
4,577 $785 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $346,489 - $394,792
2,168 Added 108.89%
4,159 $757 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $273,961 - $308,545
1,991 New
1,991 $309 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Darden Wealth Group Inc Portfolio

Follow Darden Wealth Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darden Wealth Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Darden Wealth Group Inc with notifications on news.